Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DeLiTE: Delstrigo Switch for HIV-Associated Weight Gain
NCT04665375Phase 4Terminated
- Sponsor
- University Health Network
- Start
- Apr 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by University Health Network. Started Apr 2021; status: terminated.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04665375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04665375.